Anzeige
Mehr »
Samstag, 28.02.2026 - Börsentäglich über 12.000 News
Wegweisende News: NurExone - Pionier der regenerativen neuronalen Medizin!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CRAU | ISIN: SE0015988373 | Ticker-Symbol: 7D2A
Frankfurt
27.02.26 | 08:09
0,777 Euro
-0,13 % -0,001
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SEDANA MEDICAL AB Chart 1 Jahr
5-Tage-Chart
SEDANA MEDICAL AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,7910,83313:03
0,8140,82627.02.

Aktuelle News zur SEDANA MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.02.Sedana Medical AB: Sedana Medical AB's Year-end report 2025105Positive EBITDA in our ex-US business Fourth quarter 2025Net sales for the quarter totaled MSEK 51.8 (49.2), equivalent to an increase of 5% compared to the corresponding quarter in 2024. At constant...
► Artikel lesen
27.01.Sedana Medical AB: Sedana Medical appoints Mikael Haag as Chief Financial Officer (CFO)104Sedana Medical AB (publ) announces the appointment of Mikael Haag as Chief Financial Officer (CFO) and member of the Executive Management Team. Mikael will assume his position no later than July 2026. Mikael...
► Artikel lesen
19.12.25Sedana Medical AB: CFO Johan Spetz to leave Sedana Medical358Sedana Medical AB (publ) announces today that its CFO, Johan Spetz, has decided to leave the company to pursue a new career opportunity outside of the Life Science industry. Johan Spetz has held his...
► Artikel lesen
24.11.25Sedana Medical AB: Sedana Medical reports positive pre-NDA meeting with FDA242Sedana Medical AB (publ) announces that the company has completed its pre-NDA meeting with FDA and reached broad alignment with the Agency on the contents of the New Drug Application (NDA). FDA confirmed...
► Artikel lesen
24.10.25Sedana Medical Q3 2025 presentation: Revenue miss overshadows US market progress3
24.10.25Sedana Medical: Umsatz verfehlt Erwartungen und überschattet Fortschritte in den USA2
24.10.25Sedana Medical AB: Sedana Medical AB's Interim report January-September 2025218Improved EBITDA performance amid Q3 market headwinds Third quarter 2025Net sales for the quarter totaled MSEK 41.2 (39.7), equivalent to an increase of 4% compared to the corresponding quarter 2024....
► Artikel lesen
18.07.25Sedana Medical AB: Sedana Medical AB's Interim report January-June 2025368Promising US data and strong sales growth in Q2 Second quarter 2025Net sales for the quarter totalled MSEK 49.8 (41.1), equivalent to an increase of 21% compared to the corresponding quarter 2024. At...
► Artikel lesen
SEDANA MEDICAL Aktie jetzt für 0€ handeln
06.05.25Sedana Medical AB: Sedana Medical AB's Interim report January-March 2025286Early Access in the US and a record quarter First quarter 2025Net sales for the quarter totalled MSEK 57.5 (48.8), equivalent to an increase of 18% compared to the corresponding quarter 2024. At constant...
► Artikel lesen
23.04.25Sedana Medical AB: Sedana Medical Receives FDA Approval for Early Access Program in the U.S.327Sedana Medical AB (publ) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's application to initiate an Early Access Program for its investigational inhaled sedation...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1